Medicenna Therapeutics Corp
(MDNAF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -968 | -3,588 | -2,767 | -1,482 | -805 |
| Depreciation Amortization | 1 | 5 | 4 | 3 | 1 |
| Other Working Capital | -382 | 521 | 329 | 112 | -170 |
| Other Operating Activity | -585 | -3,063 | -2,118 | -1,647 | -861 |
| Operating Cash Flow | $-1,934 | $-6,124 | $-4,552 | $-3,014 | $-1,834 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | 0 | -270 | -120 | 0 | 0 |
| Investing Cash Flow | $N/A | $-270 | $-120 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 202 | 2,728 | 2,739 | 1,204 | N/A |
| Other Financing Activity | 742 | 2,471 | 2,419 | 0 | 0 |
| Financing Cash Flow | $943 | $5,198 | $5,158 | $1,204 | $N/A |
| Exchange Rate Effect | 9 | 24 | 48 | 7 | 14 |
| Beginning Cash Position | 1,773 | 3,001 | 2,978 | 3,015 | 3,053 |
| End Cash Position | 791 | 1,807 | 3,512 | 1,082 | 1,232 |
| Net Cash Flow | $-982 | $-1,195 | $534 | $-1,932 | $-1,821 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,934 | -6,124 | -4,552 | -3,014 | -1,834 |
| Free Cash Flow | -1,934 | -6,124 | -4,552 | -3,014 | -1,834 |